Healius Limited
Research Healius Limited (HLS.AX) on Bullrun: market cap AUD 272.32M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHLS.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyAUD
- Market capAUD 272.32M
- Financial periodFY2026
Valuation Snapshot
latest market cap is AUD 272.32M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | n/a | n/a | n/a | n/a | -0.57 | n/a | n/a | n/a |
| FY2025 | AUD 1.34B | -AUD 151.20M | AUD 219.80M | 84.1% | -0.21 | AUD 57.20M | AUD 911.80M | AUD 587.90M |
| FY2024 | AUD 1.75B | -AUD 645.80M | AUD 202.80M | 87.2% | -0.98 | AUD 60.10M | AUD 1.60B | AUD 1.04B |
| FY2023 | AUD 1.71B | -AUD 367.80M | AUD 257.20M | 86.9% | -0.6 | AUD 115.30M | AUD 1.77B | AUD 1.51B |
| FY2022 | AUD 2.34B | AUD 307.90M | AUD 493.30M | 86.4% | n/a | AUD 81.30M | AUD 1.78B | AUD 1.92B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 272.32M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
| Year | Dividends/share |
|---|---|
| FY2022 | 0.15 AUD |
About Healius Limited
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab Dermatopathology, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Healius Limited's market cap?
Healius Limited's market capitalization is AUD 272.32M.
What does Healius Limited do?
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab Dermatopathology, and Agilex Biolabs brands. It operates medical laboratories and patient collection centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018.